Department of Health and Human Services
• How a firm reviewed, or plans to review, all current drug listings to identify those listings that need to be updated;
• How a firm corrected, or plans to correct, the identified errors (e.g., submit corrected SPL files for existing listings, delist NDCs no longer in use by submitting end marketing dates and changing marketing status to complete); and
• The plan or process a firm has implemented, or plans to implement, in order to prevent the recurrence of the violations.